• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Zito, Julie M
    Zhu, Yue
    Safer, Daniel J
    Date
    2021-06-14
    Journal
    Frontiers in Psychiatry
    Publisher
    Frontiers Media S.A.
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.3389/fpsyt.2021.644741
    Abstract
    Background: Psychotropic concomitant medication use for the treatment of youth with emotional and behavioral disorders has grown significantly in the U.S. over the past 25 years. The use of pharmacy claims to analyze these trends requires the following: age of the selected population, overlapping days of use, and precision of the outcome itself. This review will also address the gaps in reporting of pediatric psychotropic polypharmacy. Methods: An electronic literature search was undertaken for the period 2000 through 2020 using keywords such as "pediatric," "concomitant," "polypharmacy," "multiple medications," and "concurrent psychotropic"; Relevant references in textbooks were also used. Only English language and U.S. studies were included, resulting in 35 inter-class studies. Results: Studies were organized into seven groups according to data sources and clinical topics: (1) population surveys; (2a) multi-state publicly insured populations; (2b) single/two state studies; (3) privately insured populations; (4) diagnosed populations; (5) foster care populations; (6) special settings. Across 20 years it is apparent that pediatric psychotropic polypharmacy affects substantially more children and adolescents today than had been the case. As many as 300,000 youth now receive 3 or more classes concomitantly. The duration of concomitant use is relatively long, e.g., 69-89% of annual medicated days. Finally, more adverse event reports were associated with 3-class compared with 2-class drug regimens. Discussion: Factors that contribute to the growth of pediatric psychotropic polypharmacy include: (1) predominance of the biological model in psychiatric practice; (2) invalid assumptions on efficacy of combinations, (3) limited professional awareness of metabolic and neurological adverse drug events, and (4) infrequent use of appropriate deprescribing. Conclusion: A review of publications documenting U.S. pediatric psychotropic polypharmacy written over the last 20 years supports the need to standardize the methodologies used. The design of population-based studies should maximize information on the number of youth receiving regimens of 3-, 4-, and 5 or more concomitant classes and the duration of such use. Next, far more post-marketing research is needed to address the effectiveness, safety and tolerability of complex drug regimens prescribed for youngsters.
    Rights/Terms
    Copyright © 2021 Zito, Zhu and Safer.
    Keyword
    adolescents
    children
    concomitant psychotropic
    multiple medications or concurrent psychotropics
    pediatric
    polypharmacy
    Identifier to cite or link to this item
    http://hdl.handle.net/10713/16133
    ae974a485f413a2113503eed53cd6c53
    10.3389/fpsyt.2021.644741
    Scopus Count
    Collections
    UMB Open Access Articles

    entitlement

    Related articles

    • Characterization of Chronic Multiclass Psychotropic Polypharmacy and Psychotherapy in Foster Care Youth in a State Medicaid Population.
    • Authors: Keast SL, Tidmore LM, Shropshire D, Nesser N, Lambert TL
    • Issue date: 2019 Dec
    • Pediatric Psychotropic Polypharmacy: An Evaluation of the Correlates and Prevalence Across Assessment Cycles in the National Health and Nutrition Examination Survey.
    • Authors: Bilsky S, Blumenthal H, Ramadan B, Lewis S, Leen-Feldner EW
    • Issue date: 2022 Oct
    • Pediatric psychotropic polypharmacy.
    • Authors: Zonfrillo MR, Penn JV, Leonard HL
    • Issue date: 2005 Aug
    • Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
    • Authors: Lohr WD, Creel L, Feygin Y, Stevenson M, Smith MJ, Myers J, Woods C, Liu G, Davis DW
    • Issue date: 2018 Aug
    • Physician Care Coordination and the Use of Psychotropic Polypharmacy in the Management of Pediatric Mental Disorders.
    • Authors: Medhekar R, Fujimoto K, Aparasu RR, Bhatara VS, Johnson ML, Alonzo JP, Schwarzwald HL, Chen H
    • Issue date: 2019 Jan
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.